Gulf Medical University’s College of Pharmacy proudly celebrated a significant academic milestone as Nourhan Khaled, a student in the Master of Science in Drug Discovery and Development (MDD) program, successfully defended her thesis titled “Statistical Optimization of Stable Quercetin Nanoparticles for Tumor Targeting.”
In a compelling virtual oral defense, Nourhan presented her innovative work on engineering a stable, nanoparticle-based delivery system for quercetin—an antioxidant flavonoid with recognized anticancer potential. By applying statistical optimization techniques, she developed a robust formulation designed to enhance drug stability and precision targeting tumor cells.
The examination panel brought together a distinguished group of experts:
- Dr. Mohamed Elsawy (External Examiner), Lecturer in Pharmaceutical Sciences, University of Manchester, UK
- Prof. Shery Jacob (Internal Examiner), Professor of Pharmaceutics, College of Pharmacy, GMU
- Prof. Ibrahim El-sayed (Main Supervisor), Professor of Pharmaceutics, Cairo University and former faculty member at GMU
- Dr. Eman El-Labbad (Co-Supervisor), Assistant Professor of Medicinal Chemistry, College of Pharmacy, GMU
The session reflected Nourhan’s command over both the scientific and technical aspects of her work. The committee applauded the clarity of her presentation, the rigor of her methodology, and the translational potential of her findings in the field of targeted cancer therapy.
This successful defense marks an important achievement for Nourhan and underscores the MDD program’s continued commitment to nurturing research-driven innovation in pharmaceutical sciences. We extend our warmest congratulations to Nourhan Khaled and look forward to her future contributions to the advancement of cancer nanomedicine.